Industry 5.0 combines automation/digitalization with human capabilities to create a more intuitive, interactive, and sustainable working environment. Additive manufacturing, widely known as 3D printing, is a key technology used to increase customization and efficiency and reduce waste in manufacturing. Industry 5.0 enables manufacturers to create environmentally sustainable and consumer-centric products. However, there is a lack of studies on the introduction of AM technologies to Industry 5.0. The present study investigates the use of additive manufacturing for the fabrication of metallic parts/assemblies and the correlation between human-centric technologies, additive manufacturing, and environmental sustainability. Effective communication between these components is the key to achieving the goals of Industry 5.0, and the important parameters are shown in this article. The present work is focused on an overview and the impact of the futuristic subdivision of additive manufacturing applied to the fabrication of metallic parts/assemblies, more specifically, the 3D printing of challenging alloys or composites (such as copper alloys and/or composites with hard particles).

AbstractThis study reports the electrochemical synthesis of different morphologies of bismuth iodide and bismuth oxyiodide on graphite surfaces from acidic baths containing bismuth nitrate, sodium nitrate, iodine and ethylene glycol by a simple pH control. Linear sweep voltammetry analyses determined the potential window for the reduction of iodine where bismuth ions do not get reduced. The concentration of the iodide ions in the bath is regulated by the applied potential. At pH 0.2 and 0.5, bismuth is predominantly present as free Bi3+ ions, which react with iodide to form bismuth triiodide. On the other hand, even at slightly elevated pH 1.0 and 2.0, bismuth is predominantly complexed by water, nitrates and ethylene glycol. These complexes react with the iodide ions to form bismuth oxyiodide. Pure triiodide phase comprising polygonal platelets is obtained at pH 0.2. Pure oxyiodide phase comprising novel microflower‐like morphology formed from interlinked nano‐disks is obtained at pH 2.0.

Abstract A calcium phosphate (CaP)-based scaffold used as synthetic bone grafts, which smartly combines precise dimensions, controlled porosity and therapeutic functions, presents benefits beyond those offered by conventional practices, although its fabrication is still a challenge. The sintering step normally required to improve the strength of the ceramic scaffolds precludes the addition of any biomolecules or functional particles before this stage. This study presents a proof of concept of multifunctional CaP-based scaffolds, fabricated by additive manufacturing from an innovative ink composition, with potential for bone regeneration, cancer treatment by local magnetic hyperthermia and drug delivery platforms. Highly loaded inks comprising iron-doped hydroxyapatite and β-tricalcium phosphate powders suspended in a chitosan-based solution, in the presence of levofloxacin (LEV) as model drug and magnetic nanoparticles (MNP), were developed. The sintering step was removed from the production process, and the integrity of the printed scaffolds was assured by the polymerization capacity of the ink composite, using genipin as a crosslinking agent. The effects of MNP and LEV on the inks’ rheological properties, as well as on the mechanical and structural behaviour of non-doped and iron-doped scaffolds, were evaluated. Magnetic and magneto-thermal response, drug delivery and biological performance, such as cell proliferation in the absence and presence of an applied magnetic field, were also assessed. The addition of a constant amount of MNP in the iron-doped and non-doped CaP-based inks enhances their magnetic response and induction heating, with these effects more pronounced for the iron-doped CaP-based ink. These results suggest a synergistic effect between the iron-doped CaP-based powders and the MNP due to ferro/ferrimagnetic interactions. Furthermore, the iron presence enhances human mesenchymal stem cell metabolic activity and proliferation.